Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels. Read more about Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels.
Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. Read more about Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. Read more about Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. Read more about Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.
Serum dihydrotachysterol levels and biological action in normal man. Read more about Serum dihydrotachysterol levels and biological action in normal man.
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. Read more about Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein.
Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. Read more about Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels.
Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion. Read more about Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man. Read more about Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man.
